Cardiac Pharmaceutical Agents

The followings are medications commonly prescribed in cardiology:

Antiarrhythmic agents
- Type I (sodium channel blockers)
  - Type Ia
    - Quinidine
    - Type Ib
      - Lidocaine
      - Phenytoin
      - Type Ic
        
        Propafenone
        
        Type II (beta blockers)
        
        Metoprolol
        
        Type III (potassium channel blockers)
        
        Amiodarone
        
        Dofetilide
        
        Sotalol
        
        Type IV (slow calcium channel blockers)
        
        Diltiazem
        
        Verapamil
        
        Type V
        
        Adenosine
        
        Digoxin
        
        ACE inhibitors
        
        Captopril
        
        Enalapril
        
        Perindopril
        
        Ramipril
        
        Angiotensin II receptor antagonists
        
        Candesartan
        
        Eprosartan
        
        Irbesartan
        
        Losartan
        
        Telmisartan
        
        Valsartan
        
        Beta blocker
        
        Calcium channel blocker

This article is licensed under the Creative Commons Attribution-ShareAlike License. It uses material from the Wikipedia article on "Cardiology" All material adapted used from Wikipedia is available under the terms of the Creative Commons Attribution-ShareAlike License . Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.

Recent Cardiology News

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POSUpsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the manag...

Targeting glucagon action: A new frontier for regulating diabetesFor the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

Research reveals that US children experience gastrointestinal issuesAn increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week.

EHRA EUROPACE 2013 to feature late breaking clinical trialsAttendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.

Study reveals that heart disease risk factor management differs among outpatient practicesControl of heart disease risk factors varies widely among outpatient practices, according to a study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sess...

Cardiac Pharmaceutical Agents

Further Reading

Recent Cardiology News